TORL BioTherapeutics’ $158 Million Series B Financing Round

Crandon Law served as counsel to TORL BioTherapeutics, and Latham & Watkins served as counsel to Goldman, Sachs & Co.TORL BioTherapeutics LLC has announced its public…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here